<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mater Sociomed</journal-id><journal-id journal-id-type="iso-abbrev">Mater Sociomed</journal-id><journal-id journal-id-type="publisher-id">MSM</journal-id><journal-title-group><journal-title>Materia Socio-Medica</journal-title></journal-title-group><issn pub-type="ppub">1512-7680</issn><issn pub-type="epub">1986-597X</issn><publisher><publisher-name>AVICENA, d.o.o., Sarajevo</publisher-name><publisher-loc>Bosnia and Herzegovina</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25685078</article-id><article-id pub-id-type="pmc">4314171</article-id><article-id pub-id-type="publisher-id">MSM-26-364</article-id><article-id pub-id-type="doi">10.5455/msm.2014.26.364-365</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Paper</subject></subj-group></article-categories><title-group><article-title>Effects of Sulphate-Sulphide Mineral Water &#x0201c;Mlje&#x0010d;anica&#x0201d; in Patients with Hypertension</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Erceg-Rukavina</surname><given-names>Tatjana</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Stefanovski</surname><given-names>Mihajlo</given-names></name><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff id="aff1">Hospital for PRM &#x0201c;Mlje&#x0010d;anica&#x0201d;, Kozarska Dubica, Bosnia &#x00026; Herzegovina</aff><author-notes><corresp id="cor1">
Corresponding author: Erceg-Rukavina dr Tatjana, Trome&#x00111;e 2b Banja Luka, +387 65 737 936, Email:<email xlink:href="dr.tanjaerceg@gmail.com">dr.tanjaerceg@gmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><month>12</month><year>2014</year></pub-date><pub-date pub-type="epub"><day>14</day><month>12</month><year>2014</year></pub-date><volume>26</volume><issue>6</issue><fpage>364</fpage><lpage>365</lpage><history><date date-type="received"><day>10</day><month>8</month><year>2014</year></date><date date-type="accepted"><day>15</day><month>10</month><year>2014</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; AVICENA</copyright-statement><copyright-year>2014</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec id="st1"><title>Introduction:</title><p>Arterial hypertension is the main independent risk factor for cardiovascular (CV) disease and death. It affects development and course of cerebrovascular insult (CVI) and chronic kidney disease (CKD). Balneotherapy with sulphide baths was administered to patients having stage I hypertension (BP values 140-159/90-99), with no arrhythmia or pronounced coronary disease. Baths also had advantage in patients having hypertension joined with obesity, diabetes, microangiopathy, and atherosclerosis of peripheral arteries.</p></sec><sec id="st2"><title>Goal:</title><p>Determine the effects of sulphate-sulphide mineral baths on stage I hypertension after 10 days therapy.</p></sec><sec id="st3"><title>Materials and methods:</title><p>Patients having stage I hypertension were sent to &#x0201c;Mlje&#x0010d;anica&#x0201d; Institute for rehabilitation. All subjects were treated with kinesitherapy and electrotherapy, while experimental group (n=30) was also treated with 20 minute baths, daily, for period of 10 days.</p></sec><sec id="st4"><title>Results:</title><p>In experimental group BP level lowered in average 10 mmHg after 10-day therapy, and change was evident even after only 5 days.</p></sec><sec id="st5"><title>Conclusion:</title><p>Sulphate-sulphide mineral water &#x0201c;Mlje&#x0010d;anica&#x0201d; caused significant (p&#x0003c;0.05) lowering of arterial BP level after 10 days of therapy in patients who had stage I hypertension.</p></sec></abstract><kwd-group><kwd>sulphate-sulphide mineral water</kwd><kwd>arterial hypertension</kwd></kwd-group></article-meta></front><body><sec id="sec1-1"><title>1. INTRODUCTION</title><p>Arterial hypertension is the main independent risk factor for cardiovascular (CV) disease and death. It affects development and course of cerebrovascular insult (CVI) and chronic kidney disease (CKD). The hypertension defining threshold is flexible and it depends on blood pressure as well as on overall cardiovascular risk (<xref rid="ref1" ref-type="bibr">1</xref>). According to European Society of Hypertension (ESH) and European Society of Cardiology guidelines from 2007, stage I hypertension is defined by BP values 140-159 / 90-99. Anti-hypertension therapy in patients having stage I hypertension and high overall CV risk should begin as soon as possible. The goal of the therapy is to lower the BP to 140/90 mmHg, and in high risk patients to 130/80 mm Hg. Results of numerous trials show positive effect of sulphate-sulphide mineral water &#x0201c;Mlje&#x0010d;anica&#x0201d; in different conditions (<xref rid="ref2" ref-type="bibr">2</xref>, <xref rid="ref3" ref-type="bibr">3</xref>, <xref rid="ref4" ref-type="bibr">4</xref>). Hypothesis: Application of balneotherapy in experimental group should result in lowering stage I arterial hypertension, compared to application of hydrotherapy in control group.</p></sec><sec id="sec1-2"><title>2. GOAL</title><p>Determine the effects of sulphate-sulphide mineral baths on stage I hypertension after 10 days therapy.</p></sec><sec id="sec1-3"><title>3. METHODS</title><p>The trial is designed as controlled, randomized, prospective study. The trial protocol was approved by Institute&#x02019;s Ethics Committee and written informed consent was obtained from all participants. Participants were patients sent for rehabilitation to &#x0201c;Mlje&#x0010d;anica&#x0201d; Institute because of degenerative rheumatism (arthrosis, spondylosis), having also stage I hypertension. Patients with pronounced coronary disease, heart decompensation, hyperthyroidism or neurosis were excluded from trial. Patients were divided in two groups: experimental and control group. All the patients were treated with kinesitherapy and electrotherapy. The experimental group (n=30) was also treated daily with sulphate-sulphide mineral water baths, t=31-33 &#x000b0;C, for 20 minutes, 2 hours after breakfast, for 10 days. The control group (n=20) was treated with tap-water bath (hydrotherapy) under same conditions. &#x0201c;Mlje&#x0010d;anica&#x0201d; mineral water is rich in hydrogen sulphide ions which determine specific impact on the whole organism, penetrating the skin and somewhat mucosae (<xref ref-type="table" rid="T1">Table 1</xref>) (<xref rid="ref5" ref-type="bibr">5</xref>).</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Physical chemical analysis of sulphate-sulphide water &#x0201c;Mlje&#x0010d;anica&#x0201d;</p></caption><graphic xlink:href="MSM-26-364-g001"/></table-wrap><p>BP values were followed daily, before and after bath treatments, with mercury sphygmomanometer &#x0201c;Spirit&#x0201d;, according to ESH and ECS guidelines (<xref rid="ref6" ref-type="bibr">6</xref>, <xref rid="ref7" ref-type="bibr">7</xref>). Pharmaceutical therapy has been conducted according to ESH and ECS guidelines.</p></sec><sec id="sec1-4"><title>4. RESULTS</title><p>Total of 50 patients participated in this trial (32 women, 18 men, average age 65.47), 30 of them in experimental, 20 in control group. Groups were homogeneous regarding sex and age. There were more women in both groups. (<xref ref-type="table" rid="T2">Table 2</xref>).</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Age structure of participants</p></caption><graphic xlink:href="MSM-26-364-g002"/></table-wrap><p>In experimental group, after 10 days BP values lowered 10 mmHg in average and the decrease in values is evident already in first 5 days of therapy. <xref ref-type="fig" rid="F1">Figure 1</xref>. In control group there was no significant decrease of arterial BP values. Average decrease of 2 mmHg is noticeable on 2<sup>nd</sup> and 3<sup>rd</sup> day of therapy, but afterwards values increase again. Diastolic pressure values change in the same way as systolic pressure values in both experimental and control groups. <xref ref-type="fig" rid="F2">Figure 2</xref>. Student t-test showed statistically significant difference (0.05 significance) between average systolic BP before and after 10 days bath therapy in experimental group, which differs in control group.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Average daily values of systolic blood pressure in experimental group</p></caption><graphic xlink:href="MSM-26-364-g003"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><p>Average daily values of systolic blood presure in control group</p></caption><graphic xlink:href="MSM-26-364-g004"/></fig></sec><sec id="sec1-5"><title>5. DISCUSSION</title><p>Arterial hypertension is one of the greatest health issues of today in both developed and non-developed countries. It largely affects labour force what makes it also a socioeconomic problem. During rehabilitation of patients in &#x0201c;Mlje&#x0010d;anica&#x0201d; Institute, regulation of arterial BP was noticed in patients treated with sulphate-sulphide mineral water. Values of systolic and diastolic BP changed in the same way as a consequence of sulphide baths. It should be emphasized that this is our preliminary trial on this subject. The effects of &#x0201c;Mlje&#x0010d;anica&#x0201d; mineral water on stage 2 and 3 hypertension are still unknown, as well as long term effects on patients having stage I hypertension. However, any therapy regulating arterial BP even for short term should not be ignored.</p></sec><sec id="sec1-6"><title>6. CONCLUSION</title><p>Sulphate-sulphite mineral water &#x0201c;Mlje&#x0010d;anica&#x0201d; brought significant decrease of arterial blood pressure values in patients having stage I hypertension, only 10 days after treatment.</p></sec></body><back><fn-group><fn fn-type="conflict"><p><bold>CONFLICT OF INTEREST: NONE DECLARED.</bold></p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mancia</surname><given-names>G</given-names></name><etal/></person-group><article-title>2007 ESH-ESC Guidelines for Management of Arterial Hypertension</article-title><source>J Hypertens</source><year>2007</year><volume>25</volume><fpage>1105</fpage><lpage>1187</lpage><pub-id pub-id-type="pmid">17563527</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Stefanovski</surname><given-names>G</given-names></name><name><surname>Stefanovski</surname><given-names>M</given-names></name><name><surname>&#x00160;krbi&#x00107;</surname><given-names>R</given-names></name><name><surname>Luka&#x0010d;</surname><given-names>T</given-names></name><name><surname>Avram-&#x00160;olaja</surname><given-names>S</given-names></name><name><surname>Popara</surname><given-names>V</given-names></name></person-group><article-title>The Influence Of Sulphurous Mineral Water On Experimental Osteoporosis</article-title><year>2006</year><publisher-name>6th Mediterranean Congress Of PRM, 18-21. October 2006, Portugal</publisher-name><fpage>57</fpage></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Stefanovski</surname><given-names>G</given-names></name></person-group><article-title>Balneoterapija sulfatno-sulfidnom mineralnom vodom u rehabilitaciji bolesnika nakon cerebrovaskularnog inzulta (doktorska disertacija)</article-title><year>1999</year><publisher-loc>Beograd</publisher-loc><publisher-name>Univerzitet u Beogradu</publisher-name></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stefanovski</surname><given-names>M</given-names></name></person-group><article-title>Balneoterapija kontraktura zglobova donjih ekstremiteta nastalih usljed eksplozivnih povreda</article-title><source>Scripta medica</source><year>1995</year><volume>26</volume><issue>1-4</issue><fpage>9</fpage><lpage>12</lpage></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ti&#x00161;ma</surname><given-names>RV</given-names></name><name><surname>Stefanovski</surname><given-names>GO</given-names></name><name><surname>Stefanovski</surname><given-names>MS</given-names></name></person-group><article-title>Prirodna ljekovita sumporna voda Instituta &#x0201c;Mlje&#x0010d;anica&#x0201d;</article-title><source>Kozarska Dubica</source><year>2005</year></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pickering</surname><given-names>TG</given-names></name><name><surname>Hall</surname><given-names>JE</given-names></name><name><surname>Appel</surname><given-names>LJ</given-names></name><etal/></person-group><article-title>Recommendations for Blood Pressure Measurement in Humans and Experimental Animals: Part 1: Blood Pressure Measurement in Humans: A Statement for Professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research</article-title><source>Hypertension</source><year>2005</year><volume>45</volume><fpage>142</fpage><lpage>161</lpage><pub-id pub-id-type="pmid">15611362</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pickering</surname><given-names>TG</given-names></name></person-group><article-title>Measurement of Blood Pressure In and Out of the Office</article-title><source>J Clin Hypertens</source><year>2005</year><volume>7</volume><issue>2</issue><fpage>123</fpage><lpage>129</lpage></element-citation></ref></ref-list></back></article>